144 related articles for article (PubMed ID: 34250613)
1. Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH.
Nagasaki A; Sakamoto S; Arai T; Kato M; Ishida E; Furusho H; Fujii M; Takata T; Miyauchi M
J Clin Periodontol; 2021 Oct; 48(10):1367-1378. PubMed ID: 34250613
[TBL] [Abstract][Full Text] [Related]
2. Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation.
Nagasaki A; Sakamoto S; Chea C; Ishida E; Furusho H; Fujii M; Takata T; Miyauchi M
Sci Rep; 2020 Mar; 10(1):4134. PubMed ID: 32139740
[TBL] [Abstract][Full Text] [Related]
3. Porphyromonas gingivalis-odontogenic infection is the potential risk for progression of nonalcoholic steatohepatitis-related neoplastic nodule formation.
Sakamoto S; Nagasaki A; Shrestha M; Shintani T; Watanabe A; Furusho H; Chayama K; Takata T; Miyauchi M
Sci Rep; 2023 Jun; 13(1):9350. PubMed ID: 37291206
[TBL] [Abstract][Full Text] [Related]
4. Impact of
Liu L; Geng Y; Xiong C
Ann Med; 2023; 55(2):2255825. PubMed ID: 37708866
[No Abstract] [Full Text] [Related]
5. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice.
Furusho H; Miyauchi M; Hyogo H; Inubushi T; Ao M; Ouhara K; Hisatune J; Kurihara H; Sugai M; Hayes CN; Nakahara T; Aikata H; Takahashi S; Chayama K; Takata T
J Gastroenterol; 2013 Nov; 48(11):1259-70. PubMed ID: 23307045
[TBL] [Abstract][Full Text] [Related]
6. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease.
Yoneda M; Naka S; Nakano K; Wada K; Endo H; Mawatari H; Imajo K; Nomura R; Hokamura K; Ono M; Murata S; Tohnai I; Sumida Y; Shima T; Kuboniwa M; Umemura K; Kamisaki Y; Amano A; Okanoue T; Ooshima T; Nakajima A
BMC Gastroenterol; 2012 Feb; 12():16. PubMed ID: 22340817
[TBL] [Abstract][Full Text] [Related]
7.
Kuraji R; Ito H; Fujita M; Ishiguro H; Hashimoto S; Numabe Y
Clin Exp Dent Res; 2016 Dec; 2(3):216-225. PubMed ID: 29744170
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.
Nakahara T; Hyogo H; Ono A; Nagaoki Y; Kawaoka T; Miki D; Tsuge M; Hiraga N; Hayes CN; Hiramatsu A; Imamura M; Kawakami Y; Aikata H; Ochi H; Abe-Chayama H; Furusho H; Shintani T; Kurihara H; Miyauchi M; Takata T; Arihiro K; Chayama K
J Gastroenterol; 2018 Feb; 53(2):269-280. PubMed ID: 28741270
[TBL] [Abstract][Full Text] [Related]
9. Corosolic acid ameliorates non-alcoholic steatohepatitis induced by high-fat diet and carbon tetrachloride by regulating TGF-β1/Smad2, NF-κB, and AMPK signaling pathways.
Liu G; Cui Z; Gao X; Liu H; Wang L; Gong J; Wang A; Zhang J; Ma Q; Huang Y; Piao G; Yuan H
Phytother Res; 2021 Sep; 35(9):5214-5226. PubMed ID: 34213784
[TBL] [Abstract][Full Text] [Related]
10. Porphyromonas gingivalis exacerbates alcoholic liver disease by altering gut microbiota composition and host immune response in mice.
Gao Y; Zhang P; Wei Y; Ye C; Mao D; Xia D; Luo Y
J Clin Periodontol; 2023 Sep; 50(9):1253-1263. PubMed ID: 37381658
[TBL] [Abstract][Full Text] [Related]
11. Liver macrophages show an immunotolerance phenotype in nonalcoholic fatty liver combined with
Guo L; Liu Y; Chen Y; Xu J; Liu Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2023 Aug; 41(4):385-394. PubMed ID: 37474470
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model.
Aoyama Y; Naiki-Ito A; Xiaochen K; Komura M; Kato H; Nagayasu Y; Inaguma S; Tsuda H; Tomita M; Matsuo Y; Takiguchi S; Takahashi S
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010924
[TBL] [Abstract][Full Text] [Related]
13. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
[TBL] [Abstract][Full Text] [Related]
14. Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway.
Ahn JS; Yang JW; Oh SJ; Shin YY; Kang MJ; Park HR; Seo Y; Kim HS
BMB Rep; 2021 Jun; 54(6):323-328. PubMed ID: 34078528
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S
JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
[TBL] [Abstract][Full Text] [Related]
17. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
Linden MA; Sheldon RD; Meers GM; Ortinau LC; Morris EM; Booth FW; Kanaley JA; Vieira-Potter VJ; Sowers JR; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
J Physiol; 2016 Sep; 594(18):5271-84. PubMed ID: 27104887
[TBL] [Abstract][Full Text] [Related]
18. Histological effects and pharmacokinetics of lipopolysaccharide derived from Porphyromonas gingivalis on rat maxilla and liver concerning with progression into non-alcoholic steatohepatitis.
Fujita M; Kuraji R; Ito H; Hashimoto S; Toen T; Fukada T; Numabe Y
J Periodontol; 2018 Sep; 89(9):1101-1111. PubMed ID: 29799627
[TBL] [Abstract][Full Text] [Related]
19. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
[TBL] [Abstract][Full Text] [Related]
20. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
